Alfonso Baldi Selected Research

Alfonso Baldi Research Topics

Disease

65	Neoplasms (Cancer) 05/2022 - 07/2003
16	Endometriosis 03/2022 - 04/2008
16	Mesothelioma 03/2020 - 10/2006
9	Infarction (Infarctions) 05/2008 - 12/2002
8	Malignant Mesothelioma 03/2020 - 05/2008
8	Carcinoma (Carcinomatosis) 10/2019 - 10/2003
8	Melanoma (Melanoma, Malignant) 07/2011 - 09/2002
7	Sarcoma (Soft Tissue Sarcoma) 10/2020 - 09/2007
7	Neoplasm Metastasis (Metastasis) 06/2015 - 06/2003
6	Breast Neoplasms (Breast Cancer) 12/2019 - 06/2003
6	Lung Neoplasms (Lung Cancer) 10/2014 - 11/2002
6	Heart Failure 05/2008 - 12/2002
5	Carcinogenesis 11/2020 - 10/2003
4	Inflammation (Inflammations) 11/2020 - 06/2006
4	Hypoxia (Hypoxemia) 02/2015 - 09/2004
4	Prostatic Neoplasms (Prostate Cancer) 09/2013 - 08/2003
4	Thymoma (Thymic Carcinoma) 03/2011 - 07/2005
4	Margins of Excision 05/2008 - 02/2006
3	Myocardial Infarction 03/2009 - 09/2007
3	Atherosclerotic Plaque (Atheroma) 02/2009 - 03/2006
3	Ischemia 05/2008 - 11/2002
2	Pathologic Complete Response 01/2021 - 11/2008
2	Hyperplasia 01/2019 - 11/2007
2	Hemangiosarcoma (Angiosarcoma) 07/2017 - 01/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2017 - 06/2009
2	Lymphatic Metastasis 10/2014 - 09/2002
2	Ganglioneuroblastoma 04/2014 - 11/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2012 - 03/2012
2	Lipodystrophy 11/2012 - 02/2009
2	Cicatrix (Scar) 09/2012 - 09/2011
2	Wounds and Injuries (Trauma) 01/2012 - 01/2008
2	Fibrosarcoma 09/2011 - 11/2008
2	Stomach Neoplasms (Stomach Cancer) 04/2011 - 07/2006
2	Unstable Angina 02/2009 - 09/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2008 - 11/2003
2	Ventricular Remodeling 05/2008 - 08/2006
2	Pseudolymphoma 11/2007 - 09/2004
2	Cardiomyopathies (Cardiomyopathy) 09/2007 - 10/2004

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
17	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 07/2006
10	Pharmaceutical PreparationsIBA 11/2020 - 04/2006
10	High-Temperature Requirement A Serine Peptidase 1IBA 01/2016 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 12/2016 - 09/2009
7	Biological ProductsIBA 11/2019 - 10/2006
6	Bleomycin (Blenoxane)FDA LinkGeneric 10/2020 - 09/2007
6	Complementary DNA (cDNA)IBA 03/2012 - 09/2002
5	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 09/2002
5	Piroxicam (Feldene)FDA LinkGeneric 02/2015 - 10/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 01/2003
4	Estrogens (Estrogen)FDA Link 03/2022 - 04/2012
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 03/2006
4	Serine Proteases (Serine Protease)IBA 01/2010 - 10/2006
3	Monoclonal AntibodiesIBA 11/2020 - 06/2007
3	CurcuminIBA 03/2020 - 01/2018
3	Estrogen ReceptorsIBA 12/2019 - 01/2006
3	Cell Cycle ProteinsIBA 01/2011 - 11/2005
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010 - 11/2003
3	Zoledronic Acid (Zometa)FDA Link 11/2009 - 08/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008 - 09/2004
3	Caspase 3 (Caspase-3)IBA 02/2007 - 03/2003
3	Indicators and Reagents (Reagents)IBA 04/2004 - 09/2002
2	Cyclin D1IBA 05/2022 - 09/2008
2	ChromatinIBA 11/2020 - 03/2011
2	Phenobarbital (Luminal)FDA Link 11/2020 - 06/2015
2	Antineoplastic Agents (Antineoplastics)IBA 03/2020 - 08/2019
2	PhytochemicalsIBA 10/2019 - 08/2019
2	Bortezomib (Velcade)FDA Link 01/2019 - 04/2013
2	LipidsIBA 01/2019 - 03/2012
2	Endocrine DisruptorsIBA 10/2018 - 01/2012
2	Keratins (Keratin)IBA 09/2018 - 06/2007
2	Glycoproteins (Glycoprotein)IBA 12/2016 - 01/2014
2	Complement C3 (C3 Complement)IBA 12/2016 - 12/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2015 - 05/2008
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 11/2007
2	AntigensIBA 11/2014 - 02/2009
2	RNA (Ribonucleic Acid)IBA 09/2013 - 03/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2013 - 03/2011
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2013 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013 - 09/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2012 - 05/2009
2	PlatinumIBA 04/2011 - 05/2008
2	AntibodiesIBA 03/2011 - 02/2009
2	ErbB Receptors (EGF Receptor)IBA 02/2010 - 10/2006
2	AndrogensIBA 11/2009 - 05/2007
2	salicylhydroxamic acid (SHAM)IBA 05/2008 - 09/2007
2	tipifarnib (R115777)IBA 11/2007 - 05/2007
2	TransferasesIBA 11/2007 - 04/2006
2	parecoxibIBA 11/2007 - 06/2007
2	UbiquitinIBA 06/2006 - 03/2006
2	Rosiglitazone (Avandia)FDA Link 06/2006 - 03/2006

Therapy/Procedure

30	Therapeutics 01/2022 - 07/2004
18	Drug Therapy (Chemotherapy) 09/2014 - 02/2006
3	Radiotherapy 01/2013 - 01/2008
3	Highly Active Antiretroviral Therapy (HAART) 11/2012 - 02/2009
2	Aftercare (After-Treatment) 01/2021 - 07/2011
2	Pneumonectomy (Lung Volume Reduction) 05/2012 - 05/2008
2	Sutures (Suture) 01/2012 - 02/2006
2	Combination Drug Therapy (Combination Chemotherapy) 07/2011 - 04/2011
2	Ligation 05/2008 - 09/2007
2	Euthanasia (Mercy Killing) 09/2007 - 09/2007